Navigation Links
UL Announces RoHS II Services for Medical and Laboratory Equipment
Date:4/30/2013

NORTHBROOK, Ill., April 30, 2013 /PRNewswire/ -- UL (Underwriters Laboratories), a world leader in advancing safety, announced today the launch of a new program supporting medical devices and laboratory equipment manufacturers in their RoHS II Directive (2011/65/EU) compliance efforts.

Many manufacturers of medical and laboratory equipment previously excluded from the Scope of the original RoHS Directive are now finding that their devices are within Scope of the recast RoHS II Directive. Manufactures placing these devices in Europe must be in compliance with the new Directive by July 22, 2014.  Due diligence on the part of these manufacturers is required to ensure that their Declaration of Conformity and Technical File meets the applicable requirements.  UL offers these manufacturers support in their due diligence efforts, including a gap analysis of their process, compilation of documents supporting the technical file, analytical testing and more.

"In order to legally market devices in the EU, medical device and laboratory equipment manufacturers must comply with many regulations, including the new RoHS II Directive," said Anil Patel, vice president and general manager of UL health sciences. "This program gives manufacturers needed support in helping to ensure that their products are in full compliance with not only safety, but environmental regulations as well - an area which is receiving increasing focus world-wide."

Under the RoHS II Directive, end-product manufacturers will work with their suppliers to manage compliance and compile technical documentation as evidence of compliance. Because the approach required by the legislation is of a general nature, integrating RoHS assessment services with other regulatory assessments can help manufacturers streamline, and thereby improve, business processes.

"We view the RoHS II Directive as a positive move in protecting our environment, and right in line with our mission at UL to support the production and use of products which are physically and environmentally safe," said Mark Leimbeck , Program Manager for UL's Health Sciences Industry. "This initiative provides us an opportunity to actively engage the industry, support streamlined efforts to ensure regulatory compliance, and provide a safer and cleaner environment for our children and ourselves."

About UL

UL is a premier global independent safety science company with more than 118 years of history. Employing more than 10,000 professionals in over 100 countries, UL has five distinct business units – Product Safety, Environment, Life & Health, Knowledge Services, and Verification Services – to meet the expanding needs of our customers and to deliver on our public safety mission.  Additional information about UL may be found at UL.com.

Contact: Tara Kambeitz
Global Marketing Manager
UL
T: +1 360 263 6987
E: Tara.L.Kambeitz@ul.com


'/>"/>
SOURCE UL
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
2. NextBio Announces Translational Medicine Partnership with Sanofi
3. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
4. IRIDEX Announces Receipt of Large Orders for Laser Systems from Developing Countries
5. Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
6. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
7. FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
8. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
9. ConvaTec Announces 2012 Year-End Earnings Call
10. IRIDEX Announces First Quarter 2013 Conference Call and Release Date
11. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/11/2017)... , Aug. 11, 2017 DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... August 14 and host a conference call at 9:00am ... operating and financial results and its strategy and outlook ... hosted by Erez Raphael , Chief Executive Officer, ...
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
Breaking Medicine Technology:
(Date:8/19/2017)... ... 2017 , ... Parker at Stonegate, an assisted living residence ... caregivers, volunteers, thought leaders, researchers, educators and partners leading the way in services ... refresh the carpeting with the goal of maintaining the same precise colors and ...
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... Ca (PRWEB) , ... August 18, 2017 , ... ... quality liquid handling handheld devices. Through an educational webinar, they will present the ... users a chance to learn how easy you can automate everyday pipetting tasks. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... assistance that serves communities throughout southern Florida, is working to support the Take ... to children from low income families. , The Take Stock In Children Foundation ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, has become ... and conditions of aging, such as menopause, andropause, thyroid disorder and adrenal insufficiencies. ...
Breaking Medicine News(10 mins):